New pharmaceutical active compounds
AssigneeAstra Aktiebolag, a Sweden corporation
InventorsHakan Bergstrand, Kostas Karabelas, Peter Sjo
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstra Aktiebolag, a Sweden corporation
InventorsHakan Bergstrand, Kostas Karabelas, Peter Sjo
Estimating the term…
The present invention provides optionally substituted and/or annulated compounds of formula (I) 1 wherein X, Y, Z and A is each independently carbon or nitrogen, and at least two of X, Y, Z and A are carbon; and pharmaceutically acceptable salts thereof with the proviso that: 3-(1H-Indol-3-yl)-1H-quinoxalin-2-one, 3-(2-Methyl-1H-indol-3-yl)-1H-quinoxalin-2-one, and 3-(1,2-Diphenyl-1H-indol-3-yl)-1H-quinoxalin-2-one are excluded from compounds of formula (I). The invention includes the use of compounds of formula (I) in medical therapy, particularly in the therapy of conditions requiring inhibition of protein kinase C.
An optionally substituted and/or annulated compound of formula (I):
The compounds:
The compound:
Dependencies are inferred from the claim text.